Who
Catherine Bollard
Director
Company insider
Files Form 4 as: Director, Cabaletta Bio.
In numbers
- Trades disclosed
- 18
- Buys
- 2
- Sells
- 0
- Bought
- $21K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 1 Jun 2021
- Last trade
- 9 Jun 2026
- Last filed
- 10 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Jun 2026filed 10 Jun 2026 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 9 Jun 2026filed 10 Jun 2026 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 21 Jan 2026filed 21 Jan 2026 | CABA Cabaletta BioBiotechnology | SEC FORM 4 Bought | $9,9824,405 at $2.27 | filing |
| 21 Jan 2026filed 21 Jan 2026 | CABA Cabaletta BioBiotechnology | SEC FORM 4 Bought | $9,9994,405 at $2.27 | filing |
| 9 Jun 2025filed 9 Jun 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —46,428 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —46,428 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —22,000 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —22,000 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —22,000 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 3 Jun 2024filed 4 Jun 2024 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 1 Jun 2023filed 2 Jun 2023 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 18 Oct 2022filed 18 Oct 2022 | CABA Cabaletta BioBiotechnology | SEC FORM 4 Bought | $9901,000 at $0.99 | filing |
| 1 Jun 2022filed 3 Jun 2022 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 1 Jun 2021filed 3 Jun 2021 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.